ClinicalTrials.govpublic full text
Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial
liver cirrhosis, hepatic, cancer, carcinoma, hepatocellular, liver, cirrhosis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863545
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.